2018-11-15T07:22:01-00:00 2017-12-31 SCHNAUFER & WALKER PC 2695 VILLA CREEK 268 DALLAS TX 75234 990 2017-01-01 464870147 N of One NOFO 9728664905 6060 North Central Expwy Ste 500 Dallas TX 75206 John Rodakis President 2018-11-15 true DAVID SCHNAUFER 9727982046 2018-11-15 104.184.119.11 2018-11-16 01:19:33 CS P 0C3B34B0CD98AAB6F33A8D33D183957B092DF7C6 0C3B34B0CD98AAB6F33A8D33D183957B092DF7C6 2017 2019-02-21 02:37:17Z X N of One Autism Research Foundation John Rodakis 6060 North Central Expwy Ste 500 Dallas TX 75206 241112 false X www.NofOne.org X 2014 TX The mission is to facilitate, fund, and communicate breakthroughs in autism research that will lead to diagnostics, treatments, and prevention strategies based on an understanding of the underlying biology of autism. 4 4 0 1 0 240973 0 0 139 241112 20000 0 0 0 4899 19044 39044 202068 93265 295313 174 154 93091 295159 N of Ones mission is to facilitate, fund, and communicate breakthroughs in autism research. N of One was founded by parents and researches who believe that by focusing on the underlying biology of autism, breakthroughs that will lead to novel treatments, diagnostics, and prevention strategies are possible in our lifetime. false false 28048 20000 N of One directly funds research and actively works with researchers at top institutions to create breakthroughs for autism by focusing on historically underfunded areas that include the immune system, the microbiome, and cell metabolism. N of One has projects underway in each 1 Immune System N of One is working together with researchers at the MIND Institute at UC-Davis to investigate the role of auto-antibodies in autism using a novel technology that allows for the rapid screening of thousands of auto-antibodies at a time. 2 Microbiome N of One is collaborating with Baylor College of Medicine to elucidate the reasons behind changes of autism symptoms in some children in response to antibiotics. 3 Cell Metabolism N of One has partnered with researchers at UC - San Diego to develop a newborn screening for infants to determine their risk of autism by looking at early metabolic markers. N of One is continually identifying new, high-potential research projects that can lead to novel treatment, diagnostic, and prevention strategies in our lifetime. 3116 N of One believes that an integral part of its mission is to communicate the latest promising scientific developments to the public. N of One disseminates information via its website, social media and its periodic newsletter to subscribers. N of One works with the media and press to help support the publication of the latest scientific breakthroughs to as wide an audience as possible. In 2017 an op ed written by N of Ones founder, John Rodakis, was published in the Wall St. Journal highlighting the need to fund novel approaches to autism research. N of One has also recently launched it Research Round-up blog translating the latest autism research into an format easily understood by the non-science professional. 31164 true true false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false true X 0 0 true 0 false false false false false false false false false false X 4 4 false false false false false false false true true false false false true true true false true true true false X N of One 9728664905 6060 North Central Expwy Ste 500 Dallas TX 75206 X John Rodakis President/Chairman 040.00 X X 0 0 0 Mark Plunket Director 001.00 X 0 0 0 Marquez Bela Director 001.00 X 0 0 0 Nelson Jaeggli MD Director 001.00 X 0 0 0 false false false 240973 240973 Other income 900099 139 139 139 241112 139 20000 20000 0 0 0 0 0 0 0 0 0 0 3712 1856 1856 0 0 0 1567 1097 93 377 3236 750 2486 609 286 47 276 1211 848 121 242 0 7150 5005 715 1430 1031 934 97 0 0 53 37 11 5 0 0 0 Clinical trial expenses 61 61 Miscellaneous 414 290 41 83 0 39044 31164 2981 4899 93265 295313 93265 295313 174 154 174 154 X 93091 295159 93091 295159 93265 295313 202068 X false false false X 240973 240973 240973 240973 194682 46291 240973 X 0.00000 0.00000 0.00000 true Univ of CA San Diego Sch of Medicine 9500 Gilman La Jolla CA 92093 20000 Research 1 Form 990, Part VI, Section B, Line 11a The 990 is reviewed by the officer who signs it before it is mailed to the IRS. Form 990, Part V, Section B, Line 12c The board of directors must disclose any conflicts of interest at its board meetings. Form 990, Part VI, Section B, Line 15 Compensation is approved by the Board of Directors. Form 990, Part VI, Section C, Line 19 The 990, which contains the nonprofit organizations financial statements, is available upon request.